FindTrial
Sign In

To Validate the Risk Scoring System that is developed by Madras Medical Mission, to predict whether the contrast used during the procedure of angioplasty would result in any alteration of kidney function

Validation of Risk Scoring System to Predict Contrast Induced Nephropathy Following Percutaneous Coronary Intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/10/005080
Enrollment
5000
Registered
2014-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Contrast use during the Percutaneous Coronary Intervention would result in any alteration of kidney function

Interventions

None listed

Sponsors

The Madras Medical Mission Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive Indian patients aged 18 to 80 years, who undergo PCI in the study sites will be enrolled into the study.

Exclusion criteria

Exclusion criteria: Patients with renal failure on regular dialysis, evidence of acute renal failure before PCI, cardiogenic shock, patients who were exposed to contrast media within 14 days, patients requiring intra-aortic balloon pump (IABP) support and patients who developed PCI related complications will be ex¬cluded. Patients on Nephrotoxic medication

Design outcomes

Primary

MeasureTime frame
To assess the Validity of Risk Scoring System to Predict Contrast Induced Nephropathy Following Percutaneous Coronary Intervention developed by Victor et.al,.Timepoint: 48 hours—

Secondary

MeasureTime frame
1. To assess the observed Vs expected chronic induced nephropathy rates using the scoring system provided by Victor et.al., 2. To compare the performance of risk scoring system to that of Mehram risk scoring system for chronic induced nephropathy 3. To determin the incidence of chronic induced in the study group of the patient undergoing PCI Timepoint: 48 hours—

Countries

India

Contacts

Public ContactSuma Victor

The Madras Medical Mission

clireco@mmm.org.in04426565974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026